Albumedix

Albumedix, now part of the life sciences group Sartorius, is an innovation-focused biotechnology company well recognized as a leader in albumin-enabled solutions. With a mission dedicated to better health, over nearly four decades of commitment, Albumedix has supported its partners to deliver safe doses globally, in development, clinical phase and marketed therapeutics, to millions of patients. Albumedix' portfolio of solutions includes the world's only USP-NF-compliant recombinant human albumin (Recombumin®); client-centric services, and proprietary drug-enhancing technology (Veltis®)

Company Type
Twitter Account
@Albumedix